ZYN002
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 2
Sponsors and Collaborators
Zynerba
Mechanism of Action
Cannabinoids
Mechanism Description
Transdermal cannabidiol gel
Populations Tested In
Adult Refractory Focal Epilepsy; Developmental and Epileptic Encephalopathies (DEE) (including Ohtahara, West, Landau-Kleffner, Lennox-Gastaut, Doose and Dravet ).
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link